Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon Hall

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 15, 2025
Rates of clinical progression according to biological Alzheimer's disease stagesLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2026
Visual versus quantitative tau-PET Braak staging in Alzheimer's disease using [<sup>18</sup>F]MK6240Arthur C Macedo, Karine Provost, Jean-Paul Soucy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
APOE ɛ4 carriership determines a faster plasma p-tau217 progression in Aβ-positive individualsMarcel S Woo, Arthur C Macedo, Seyyed Ali Hosseini, et al.
Brain : a Journal of Neurology|January 20, 2026
Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy dataLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
EMBO Molecular Medicine|October 10, 2025
Glia inflammation and cell death pathways drive disease progression in preclinical and early ADMarcel S Woo, Joseph Therriault, Seyyed Ali Hosseini, et al.
Molecular Neurodegeneration|June 5, 2026
Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer's diseaseArthur C Macedo, Lydia Trudel, Seyyed Ali Hosseini, et al.
Communications Medicine|November 20, 2025
APOE ε4 potentiates tau related reactive astrogliosis assessed by cerebrospinal fluid YKL40 in Alzheimer's diseaseLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2025
Tau profiling across Alzheimer's disease staging reveals vulnerability to disease pathophysiologyGleb Bezgin, Tharick A Pascoal, Joseph Therriault, et al.
Brain : a Journal of Neurology|January 29, 2025
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrumJaime Fernández Arias, Wagner S Brum, Gemma Salvadó, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 9, 2026
Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areasSeyyed Ali Hosseini, Stijn Servaes, Arthur C Macedo, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 15, 2025
Rates of clinical progression according to biological Alzheimer's disease stagesLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2026
Visual versus quantitative tau-PET Braak staging in Alzheimer's disease using [<sup>18</sup>F]MK6240Arthur C Macedo, Karine Provost, Jean-Paul Soucy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
APOE ɛ4 carriership determines a faster plasma p-tau217 progression in Aβ-positive individualsMarcel S Woo, Arthur C Macedo, Seyyed Ali Hosseini, et al.
Brain : a Journal of Neurology|January 20, 2026
Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy dataLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
EMBO Molecular Medicine|October 10, 2025
Glia inflammation and cell death pathways drive disease progression in preclinical and early ADMarcel S Woo, Joseph Therriault, Seyyed Ali Hosseini, et al.
Molecular Neurodegeneration|June 5, 2026
Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer's diseaseArthur C Macedo, Lydia Trudel, Seyyed Ali Hosseini, et al.
Communications Medicine|November 20, 2025
APOE ε4 potentiates tau related reactive astrogliosis assessed by cerebrospinal fluid YKL40 in Alzheimer's diseaseLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2025
Tau profiling across Alzheimer's disease staging reveals vulnerability to disease pathophysiologyGleb Bezgin, Tharick A Pascoal, Joseph Therriault, et al.
Brain : a Journal of Neurology|January 29, 2025
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrumJaime Fernández Arias, Wagner S Brum, Gemma Salvadó, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 9, 2026
Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areasSeyyed Ali Hosseini, Stijn Servaes, Arthur C Macedo, et al.
Pageof 4